ScholarIQanswers from OpenAlex & ORCID
François‐Clément Bidard
ResearcherPublications, citations & collaboration network
François‐Clément Bidard is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does François‐Clément Bidard have?
ScholarIQindexed works
François‐Clément Bidard has 546 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does François‐Clément Bidard have?
ScholarIQcitation count
François‐Clément Bidard has 16,808 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of François‐Clément Bidard?
ScholarIQh-index
François‐Clément Bidard has an h-index of 66 in OpenAlex.
What is the i10-index of François‐Clément Bidard?
ScholarIQi10-index
François‐Clément Bidard has an i10-index of 193 in OpenAlex.
What is the ORCID of François‐Clément Bidard?
ScholarIQorcid
The ORCID for François‐Clément Bidard is on the source record.
What is the OpenAlex record for François‐Clément Bidard?
ScholarIQopenalex
The OpenAlex for François‐Clément Bidard is on the source record.
What are the most-cited papers on François‐Clément Bidard?
ScholarIQmost cited works
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
François‐Clément Bidard, Virginia Kaklamani, Patrick Neven, Guillermo Streich, Alberto J. Montero, Frédéric Forget, Marie‐Ange Mouret‐Reynier, Joohyuk Sohn, Donatienne Taylor, Kathleen Harnden, Hung T. Khong, Judit Kocsis, Florence Dalenc, Patrick M. Dillon, Sunil Babu, Simon Waters, Ines Deleu, José Á. García-Sáenz, Emilio Bria, Marina Elena Cazzaniga, Janice Lu, Philippe Aftimos, Javier Cortés, Shubin Liu, Giulia Tonini, Dirk Laurent, Nassir Habboubi, Maureen G. Conlan, Aditya Bardia
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Javier Pascual, Gerhardt Attard, François‐Clément Bidard, Giuseppe Curigliano, Leticia De Mattos‐Arruda, Maximilian Diehn, Antoîne Italiano, Johan Lindberg, Jason D. Merker, Clara Montagut, Nicola Normanno, Klaus Pantel, George Pentheroudakis, Sanjay Popat, Jorge S. Reis‐Filho, Jeanne Tie, Joan Seoane, N. Tarazona, Takayuki Yoshino, Nicholas C. Turner
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Wolfgang Janni, Brigitte Rack, Leon W.M.M. Terstappen, Jean‐Yves Pierga, Florin‐Andrei Taran, Tanja Fehm, Carolyn Hall, Marco R. de Groot, François‐Clément Bidard, Thomas W. P. Friedl, Peter A. Fasching, Sara Y. Brucker, Klaus Pantel, Anthony Lucci
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
François‐Clément Bidard, François-Clément Bidard, Anne‐Claire Hardy‐Bessard, Florence Dalenc, Thomas Bachelot, Jean-Yves Pierga, Thibault de la Motte Rouge, Renaud Sabatier, Coraline Dubot, Jean-Sébastien Frenel, Jean Marc Ferrero, Sylvain Ladoire, Christelle Levy, Marie-Ange Mouret-Reynier, Alain Lortholary, Julien Grenier, Camille Chakiba, Laetitia Stefani, Jérôme Edouard Plaza, Florian Clatot, Luis Teixeira, Véronique D'Hondt, Hélène Vegas, Olfa Derbel, Claire Garnier-Tixidré, Jean-Luc Canon, Barbara Pistilli, Fabrice André, Laurent Arnould, Anne Pradines, Ivan Bièche, Céline Callens, Jérôme Lemonnier, Frédérique Berger, Suzette Delaloge, Francois-Clement BIDARD, Francois-Clement BIDARD, Barbara PISTILLI, Florence DALENC, Thomas BACHELOT, Thibault De La Motte Rouge, Renaud SABATIER, Coraline DUBOT, Jean-Sébastien FRENEL, Jean-Marc FERRERO, Sylvain Ladoire, Christelle LEVY, Marie-Ange MOURET-REYNIER, Anne-Claire HARDY-BESSARD, Alain Lortholary, Julien GRENIER, Camille Chakiba, Laetitia STEFANI, P Soulié, Jean-Philippe Jacquin, Jérôme Edouard PLAZA, Florian CLATOT, Luis TEIXEIRA, Véronique D’Hondt, Hélène VEGAS, Olfa DERBEL, Claire Garnier Tixidre, Catherine Delbaldo, Lionel MOREAU, Caroline Cheneau, Jean-François Paitel, Chantal BERNARD-MARTY, Dominique Spaëth, Dominique Genet, Isabelle MOULLET, Nathalie BONICHON-LAMICHHANE, Laura DEIANA, Charlotte GREILSAMER, Laurence Venat‐Bouvet, Valérie Delecroix, Adrien MELIS, Hubert Orfeuvre, Suzanne Nguyen, Éric Legouffe, Alain Zannetti, Romuald Le Scodan, Nadine Dohollou, Philippe DALIVOUST, Olivier Arsène, Nathalie MARQUES, Thierry Petit, Delphine MOLLON, Jérôme Dauba, Nathalie Bonnin, François MORVAN, Miriam Gardner, Adina MARTI, Charles-Briac Levaché, Emma Lachaier, Mihaela ACHILLE, Christophe VALMAR, Ryan Bouaita, Jacques Médioni, Cyril Foa, Chantal BERNARD-MARTY
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
François‐Clément Bidard, Stefan Michiels, Sabine Riethdorf, Volkmar Müller, Laura J. Esserman, Anthony Lucci, Bjørn Naume, Jun Horiguchi, Rafael Gisbert‐Criado, Stefan Sleijfer, Masakazu Toi, José Á. García-Sáenz, Andreas D. Hartkopf, Daniele Generali, Françoise Rothé, Jeffrey B. Smerage, Laura Muinelo‐Romay, Justin Stebbing, Patrice Viens, Mark Jesus M. Magbanua, Carolyn Hall, Olav Engebraaten, Daisuke Takata, José Vidal-Martínez, Wendy Onstenk, Noriyoshi Fujisawa, Eduardo Díaz‐Rubio, Florin‐Andrei Taran, Maria Rosa Cappelletti, Michail Ignatiadis, Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel